Evaluation of use of a new chromogenic agar in detection of urinary tract pathogens

Journal of Clinical Microbiology

Volumn 36, Issue 4, 1998, Pages 990-994

  Samra, Z ^a,b   Heifetz, M ^a,b   Talmor, J ^c   Bain, E ^c   Bahar, J ^c  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HY LABORATORIES LTD   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CHROMOGENIC SUBSTRATE;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONTROLLED STUDY; CULTURE MEDIUM; ESCHERICHIA COLI; INOCULATION; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS SAPROPHYTICUS; URINARY TRACT INFECTION;

ACINETOBACTER; CITROBACTER; ENTEROBACTER; ESCHERICHIA COLI; KLEBSIELLA; PROTEUS MIRABILIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0031893106     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.4.990-994.1998     Document Type: Article

References (16)

1. Alon, U., G. Davidai, M. Berant, and D. Merzbach. 1987. Five-year survey of changing patterns of susceptibility of bacterial uropathogens to trimethoprim-sulfamethoxazole and other antimicrobial agents. Antimicrob. Agents Chemother. 31:126-128.
2. Ashkenazi, S., S. Even-Tov, Z. Samra, and G. Dinari. 1991. Uropathogens of various childhood populations and their antibiotic susceptibility. Pediatr. Infect. Dis. J. 10:742-746.
3. Bauer, A. M., W. M. M. Kirby, J. C. Sherris, and M. Turck. 1966. Antibiotic susceptibility testing by a standardized simple disk method. Am. J. Clin. Pathol. 45:493-496.
4. Daifuku, R., and W. E. Stamm. 1984. Association of rectal and urethral colonization with urinary tract infection in patients with indwelling catheters. JAMA 252:2028-2030.
5. Damron, D. J., J. W. Warren, G. R. Chippendale, and J. H. Fenney. 1986. Do clinical microbiology laboratories report complete bacteriology in urine from patients with long-term urinary catheters? J. Clin. Microbiol. 24:400-404.
6. Edberg, S. C., and C. M. Kontnick. 1986. Comparison of β-glucoronidase-based substrate systems for identification of Escherichia coli. J. Clin. Microbiol. 24:368-371.
7. Edberg, S. C., and R. W. Trepeta. 1983. Rapid and economical identification and antimicrobial susceptibility test methodology for urinary tract pathogens. J. Clin. Microbiol. 18:1287-1291.
8. Emori, T. G., and R. P. Gaynes. 1993. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Rev. 6:428-442.
9. Freydiere, A. M., and Y. Gille. 1994. Yeast: appearance of colonies on CHROMagar Candida. Presented at IVMS Congress 94, 7th International Congress of Mycology Division, Prague, Czech Republic.
10. Marray, B. E. 1990. Problems and mechanisms of antimicrobial resistance. Infect. Dis. Clin. North Am. 3:423-439.
11. Merlino, J., S. Siarakas, G. J. Robertson, G. R. Funnell, T. Gottlieb, and R. Bradbury. 1996. Evaluation of CHROMagar Orientation for differentiation and presumptive identification of gram-negative bacilli and Enterococcus species. J. Clin. Microbiol. 34:1788-1793.
12. National Committee for Clinical Laboratory Standards. 1979. Performance standards for antimicrobic disc susceptibility tests. Approved standard ASM-2. National Committee for Clinical Laboratory Standards, Villanova, PA.
13. Neu, C. H. 1985. Infections due to gram negative bacteria: an overview, session VIII. Rev. Infect. Dis. 7(Suppl. 4):S778-S782.
14. Odds, F. C., and R. Bernaerts. 1994. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol. 32:1923-1929.
15. Schaberg, D. R., D. H. Culver, and R. P. Gaynes. 1991. Major trend in the microbiology and etiology of nosocomial infections. Am. J. Med. 91(Suppl. 3B):72S-75S.
16. Slak, R. 1984. Review of bacterial resistance: a challenge to the treatment of urinary infection. J. Antimicrob. Chemother. 13(Suppl. B):1-7.